IOA-244 (roginolisib)
oral QD non-competitive PI3Kd inhibitor Ph. I in metastatic cancers from focused kinase inhibitor screen (60K cmpds) + opt. Cancer Res. Commun., April 14, 2023 Merck Serono / iOnctura, CH
Molecules of the Month - April 2023
oral QD non-competitive PI3Kd inhibitor Ph. I in metastatic cancers from focused kinase inhibitor screen (60K cmpds) + opt. Cancer Res. Commun., April 14, 2023 Merck Serono / iOnctura, CH
Molecules of the Month - April 2023